Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice
暂无分享,去创建一个
[1] J. Steele,et al. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[2] Jianping Ye,et al. Sodium butyrate epigenetically modulates high‐fat diet‐induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning , 2015, British journal of pharmacology.
[3] L. Forzani,et al. Administration of caseinomacropeptide-enriched extract to mice enhances the calcium content of femur in a low-calcium diet , 2015 .
[4] D. Ney,et al. Dietary Protein Source Impacts Bone, Acid Load and Calcium Excretion in Murine and Human Phenylketonuria , 2015 .
[5] K. Sjögren,et al. Effects of the gut microbiota on bone mass , 2015, Trends in Endocrinology & Metabolism.
[6] Jeroen A. A. Demmers,et al. Proteomic signatures of extracellular vesicles secreted by nonmineralizing and mineralizing human osteoblasts and stimulation of tumor cell growth , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] R. Trivedi,et al. Micro-architectural changes in cancellous bone differ in female and male C57BL/6 mice with high-fat diet-induced low bone mineral density. , 2014, The British journal of nutrition.
[8] X. Mao,et al. Ameliorating effects of casein glycomacropeptide on obesity induced by high-fat diet in male Sprague-Dawley rats. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[9] K. Petersen,et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. , 2013, Endocrinology.
[10] V. Holcomb,et al. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance , 2012, European Journal of Nutrition.
[11] P. Carlsson,et al. Female Mice are Protected against High-Fat Diet Induced Metabolic Syndrome and Increase the Regulatory T Cell Population in Adipose Tissue , 2012, PloS one.
[12] D. Ney,et al. Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet , 2012, PloS one.
[13] D. Ney,et al. Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria. , 2012, Journal of the Academy of Nutrition and Dietetics.
[14] B. Spiegelman,et al. Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.
[15] D. Ney,et al. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria. , 2012, American journal of physiology. Endocrinology and metabolism.
[16] E. Orwoll,et al. Obesity and fracture in men and women: An epidemiologic perspective , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] Andrea P. Clavijo,et al. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. , 2011, Journal of agricultural and food chemistry.
[18] R. Vanderby,et al. Linkage mapping of principal components for femoral biomechanical performance in a reciprocal HCB-8 × HCB-23 intercross. , 2011, Bone.
[19] William N. Venables,et al. Modern Applied Statistics with S , 2010 .
[20] P. Requena,et al. Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis. , 2010, The Journal of nutrition.
[21] I. Reid. Fat and bone. , 2010, Archives of biochemistry and biophysics.
[22] D. Ney,et al. Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria. , 2010, Molecular genetics and metabolism.
[23] P. Guilloteau,et al. Is caseinomacropeptide from milk proteins, an inhibitor of gastric secretion? , 2010, Regulatory Peptides.
[24] M. Ibrahim. Subcutaneous and visceral adipose tissue: structural and functional differences , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[25] Robert V Farese,et al. SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation , 2009, Nature.
[26] S. Mittelman,et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. , 2009, The Journal of clinical endocrinology and metabolism.
[27] R. Vanderby,et al. Quantitative trait loci for biomechanical performance and femoral geometry in an intercross of recombinant congenic mice: restriction of the Bmd7 candidate interval , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] K. Strissel,et al. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. , 2009, Endocrinology.
[29] M. Westerterp-Plantenga,et al. Effects of complete whey-protein breakfasts versus whey without GMP-breakfasts on energy intake and satiety , 2009, Appetite.
[30] M. Febbraio,et al. Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet–Induced Insulin Resistance , 2009, Diabetes.
[31] P. Moughan,et al. The influence of whey protein and glycomacropeptide on satiety in adult humans , 2009, Physiology & Behavior.
[32] Y. Kim,et al. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. , 2008, Nutrition.
[33] P. Clifton,et al. Whey protein isolate and glycomacropeptide decrease weight gain and alter body composition in male Wistar rats , 2008, British Journal of Nutrition.
[34] P. Clifton,et al. The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk. , 2008, The American journal of clinical nutrition.
[35] A. Daddaoua,et al. Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17 , 2008, British journal of pharmacology.
[36] B. Burton-Freeman. Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK) , 2008, Physiology & Behavior.
[37] T. Travison,et al. Lean Mass and Not Fat Mass Is Associated With Male Proximal Femur Strength , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] P. Chambon,et al. Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts , 2007, Cell.
[39] N. Turner,et al. Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle , 2007, Diabetes.
[40] Mone Zaidi,et al. Skeletal remodeling in health and disease , 2007, Nature Medicine.
[41] P. Puigserver,et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.
[42] S. Teitelbaum. Osteoclasts: what do they do and how do they do it? , 2007, The American journal of pathology.
[43] G. Karsenty,et al. Convergence between bone and energy homeostases: leptin regulation of bone mass. , 2006, Cell metabolism.
[44] R. López-Fandiño,et al. Health effects and technological features of caseinomacropeptide , 2006 .
[45] J. Tobias,et al. Adipose tissue stimulates bone growth in prepubertal children. , 2006, The Journal of clinical endocrinology and metabolism.
[46] J. Eisman,et al. Abdominal fat and hip fracture risk in the elderly: The Dubbo Osteoporosis Epidemiology Study , 2005, BMC musculoskeletal disorders.
[47] T. K. O'Neil,et al. Accuracy and precision of PIXImus densitometry for ex vivo mouse long bones: comparison of technique and software version. , 2004, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[48] W. Aimutis. Bioactive properties of milk proteins with particular focus on anticariogenesis. , 2004, The Journal of nutrition.
[49] M. Etzel,et al. Manufacture and use of dairy protein fractions. , 2004, The Journal of nutrition.
[50] I. Reid. Relationships among body mass, its components, and bone. , 2002, Bone.
[51] G. Cooney,et al. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. , 2002, Diabetes.
[52] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[53] A. Thorburn,et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] T. Martin,et al. Therapeutic approaches to bone diseases. , 2000, Science.
[55] C. Steppan,et al. Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.
[56] C H Turner,et al. Three rules for bone adaptation to mechanical stimuli. , 1998, Bone.
[57] F. Levenez,et al. Effects of gastric digestive products from casein on CCK release by intestinal cells in rat , 1994 .
[58] David W. Scott. The New S Language , 1990 .
[59] P. Jollès,et al. CASEINO-GLYCOPEPTIDES: CHARACTERIZATION OF A METHIONINE RESIDUE AND OF THE N-TERMINAL SEQUENCE. , 1965, Biochemical and biophysical research communications.
[60] Karl Pearson F.R.S.. LIII. On lines and planes of closest fit to systems of points in space , 1901 .
[61] R. Shahar,et al. Effect of peripherally administered leptin antagonist on whole body metabolism and bone microarchitecture and biomechanical properties in the mouse. , 2014, American journal of physiology. Endocrinology and metabolism.
[62] H. J. Yoo,et al. The differential relationship between fat mass and bone mineral density by gender and menopausal status , 2011, Journal of Bone and Mineral Metabolism.
[63] Robert V Farese,et al. SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation , 2010 .
[64] R. Ritchie,et al. Reduced size-independent mechanical properties of cortical bone in high-fat diet-induced obesity. , 2010, Bone.
[65] P. Clifton,et al. Effect of glycomacropeptides (GMP) on satiety hormones and food intake , 2009 .
[66] T. Elsasser,et al. Epigenetic regulation of genomes: nutrient-specific modulation of genetic networks in bovine cells. , 2008, Developments in biologicals.
[67] P. Chambon,et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. , 2007, Cell.
[68] Y. Obara,et al. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. , 2007, Cellular signalling.
[69] A. Aljada,et al. Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.
[70] Brian D. Ripley,et al. Modern applied statistics with S, 4th Edition , 2002, Statistics and computing.
[71] T Hashimoto,et al. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. , 2001, Annual review of nutrition.
[72] T. Hashimoto,et al. PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .
[73] G. Forbes,et al. Lean body mass in obesity. , 1983, International journal of obesity.
[74] Pei-shan Wu,et al. Biochemical and Biophysical Research Communications , 1960, Nature.